Jane Street’s Checkpoint Therapeutics CKPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-12,100
Closed -$48.9K 9747
2025
Q1
$48.9K Buy
+12,100
New +$40.3K ﹤0.01% 9003

Jane Street's CKPT Position: Q2 2025 in Review

Jane Street sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 98,308 shares — an estimated $397K sold.

Jane Street first reported a position in CKPT in Q2 2019 and held it in 9 quarters. The position peaked at $397K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

  • Jane Street reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Jane Street sold 98,308 Checkpoint Therapeutics shares in Q2 2025, an estimated $397K.
  • Jane Street first reported a position in Checkpoint Therapeutics in Q2 2019 and held it in 9 quarters.
  • Jane Street's Checkpoint Therapeutics position peaked at $397K in Q1 2025.
  • 0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.